{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:46:55Z","timestamp":1780472815219,"version":"3.54.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/bor.0000000000000095","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T15:20:29Z","timestamp":1405092029000},"page":"585-591","source":"Crossref","is-referenced-by-count":3,"title":["Use of microarrays in the clinical practice of pediatric rheumatology"],"prefix":"10.1097","volume":"26","author":[{"given":"Marilynn","family":"Punaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40291-013-0077-9","article-title":"Prognostic and predictive biomarkers: tools in personalized oncology.","volume":"18","author":"Nalejska","year":"2014","journal-title":"Mol Diagn Ther"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2010\/130861","article-title":"Systems biology and the discovery of diagnostic biomarkers.","volume":"28","author":"Wang","year":"2010","journal-title":"Dis Markers"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11427-013-4445-9","article-title":"Understanding human diseases with high-throughput quantitative measurement and analysis of molecular signatures.","volume":"56","author":"Yang","year":"2013","journal-title":"Sci China Life Sci"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/art.37909","article-title":"Current perspectives on systems immunology approaches to rheumatic diseases.","volume":"65","author":"Chiche","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/ar1015","article-title":"Microarray analysis of gene expression in lupus.","volume":"5","author":"Crow","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1126\/science.6176024","article-title":"Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.","volume":"216","author":"Preble","year":"1982","journal-title":"Science"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","article-title":"Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.","volume":"227","author":"Ronnblom","year":"1990","journal-title":"J Intern Med"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogrens syndrome.","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun"},{"key":"R12-17-20210128","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R14-17-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"R15-17-20210128","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"key":"R16-17-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acr.21558","article-title":"Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.","volume":"64","author":"Mina","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R17-17-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.37785","article-title":"Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon alpha-kinoid.","volume":"65","author":"Lauwerys","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R18-17-20210128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.bor.0000169363.69066.d0","article-title":"Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis.","volume":"17","author":"Adams","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R19-17-20210128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.","volume":"34","author":"de Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R20-17-20210128","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"R21-17-20210128","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1084\/jem.20070070","article-title":"Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.","volume":"204","author":"Allantaz","year":"2007","journal-title":"J Exp Med"},{"key":"R22-17-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R23-17-20210128","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3899\/jrheum.121131","article-title":"Follistatin-like protein 1 and the ferritinerythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.","volume":"40","author":"Gorelik","year":"2013","journal-title":"J Rheumatol"},{"key":"R24-17-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.37776","article-title":"Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis.","volume":"65","author":"Simonini","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R25-17-20210128","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2012-202082","article-title":"Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.","volume":"72","author":"Balow","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R26-17-20210128","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R27-17-20210128","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/ar4280","article-title":"Genomic characterization of remission in juvenile idiopathic arthritis.","volume":"15","author":"Jiang","year":"2013","journal-title":"Arthritis Res Ther"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:32:38Z","timestamp":1620948758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201409000-00017"}},"subtitle":["the future is now?"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000095","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}